Sara Blum Sherman

Investor Relations Contact chez EXSCIENTIA PLC

Health Technology

Technology Services

Profil

Sara Blum Sherman is currently working as Vice President-Investor Relations at Exscientia AI Ltd. and Exscientia Plc.
She previously worked as Senior Director-Investor Relations & Strategy at DBV Technologies SA from 2016 to 2020 and as Head-Investor Relations at UroGen Pharma Ltd.

Postes actifs de Sara Blum Sherman

Sociétés	Poste	Début
EXSCIENTIA PLC	Investor Relations Contact	01/08/2021
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Investor Relations Contact	-

Tous les postes actifs de Sara Blum Sherman

Anciens postes connus de Sara Blum Sherman

Sociétés	Poste	Fin
UROGEN PHARMA LTD.	Investor Relations Contact	01/08/2021
DBV TECHNOLOGIES	Public Communications Contact	01/09/2020

Voir l'expérience en détail de Sara Blum Sherman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sara Blum Sherman

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
DBV Technologies SA DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy	Health Technology
UroGen Pharma Ltd. UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies	Health Technology
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Health Technology
Exscientia Plc Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services	Technology Services